Ben‐Niklas Baermann

Statistics

Publications

Citations

143

H-Index

Active since

2023

Affiliations

Heinrich Heine University Düsseldorf(Current)

Düsseldorf University Hospital

Universität Hamburg

University Hospital Schleswig-Holstein

University Hospital Leipzig

Ben‐Niklas Baermann is an author at Heinrich Heine University Düsseldorf specializing in oncology, cell therapy, and chimeric antigen receptor t-cell therapy.

Publications per year

2023–2025

Publications

Aggressive Lymphoma after CD19 CAR T-Cell Therapy

Guido Kobbe, Monika Brüggemann, Ben‐Niklas Baermann et al. · New England Journal of Medicine · 2024 · 44 citations · Full text

Life Sciences, Oncology, Cancer Immunology +14

Early combination therapy of COVID-19 in high-risk patients

Hans Martin Orth, Charlotte Flasshove, Moritz Berger et al. · Infection · 2023 · 38 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy

Maximilian Merz, Danai Dima, Hamza Hashmi et al. · Blood Cancer Journal · 2024 · 22 citations · Full text

Life Sciences, Immunology, Oncology +17

Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignancies

Malte Jacobsen, Rahil Gholamipoor, Till A. Dembek et al. · npj Digital Medicine · 2023 · 15 citations · Full text

Medicine, Hematology, Oncology +15

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies

Felicitas Schulz, Paul Jäger, Johanna Tischer et al. · Cancers · 2024 · 14 citations · Full text

Medicine, Immunology, Chemotherapy +14

1–5 of 6